Clinical Trial

Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate

Study acronym: EVOOW
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) mix, removes more Fluticasone Propionate (FP) from the mouth than Water alone. 2 strengths of the EVOOW mix will be tested, one with equal parts EVOO and Water (50/50) and one with 3 parts EVOO and 1 part Water (75/25). Removing more FP deposits may help decrease the risk for obstructive sleep apnea (OSA), candidiasis (thrush), and speech and swallow dysfunction. Participants will be on study for up to 3 weeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-17.
Trial Details
NCT Number NCT07664527
Lead Sponsor University of Wisconsin, Madison
Conditions Asthma
Enrollment 20 participants
Start Date 2026-08
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-29